Advertisement

CHEST 2026


  • Explore enlightening abstracts and case reports at CHEST 2026

    Explore enlightening abstracts and case reports at CHEST 2026

    Thousands of oral, rapid-fire, and poster presentations will reveal novel findings, showcase fresh perspectives, spark exciting collaborations, and potentially even shape the future of pulmonary, critical care, and sleep medicine.


  • Experts to share updates in diagnosis, care of alpha-1 antitrypsin deficiency

    Experts to share updates in diagnosis, care of alpha-1 antitrypsin deficiency

    Emerging diagnostic algorithms and advances in therapy could transform management of alpha-1 antitrypsin deficiency, an often-overlooked genetic disease that affects the lungs and the liver, said Malik Khurram Khan, MD, FCCP.


  • Clinicians to explore timely recognition, treatment of autoimmune crises in ICU

    Clinicians to explore timely recognition, treatment of autoimmune crises in ICU

    Rheumatologic diseases can be difficult to recognize when encountered in the ICU. Missing these diagnoses can delay life-saving therapies and significantly impact patients’ outcomes, said Rami Batarseh, MD, FCCP.



  • Featured speakers to share insights from impactful chest medicine careers

    Featured speakers to share insights from impactful chest medicine careers

    CHEST 2026 Honor and Memorial Lectures will recognize individuals who have advanced work in critical care, interventional medicine, mechanical ventilation, medical education, and other areas.


  • Thoracic oncology at CHEST 2026: Breaking down guidelines, AI, and gray zones for all experts

    Thoracic oncology at CHEST 2026: Breaking down guidelines, AI, and gray zones for all experts

    Sessions spanning lung cancer diagnosis, interventional pulmonology, and radiology will reflect the fast-moving field and the real-world questions clinicians face every day in practice, said Jose De Cardenas, MD, FCCP.


  • Turn CHEST 2026 into a team-building opportunity by attending with colleagues

    Turn CHEST 2026 into a team-building opportunity by attending with colleagues

    Attending the CHEST Annual Meeting as a group allows coworkers to learn together, support each other, and grow closer as a team, said Sarah Tomashefski, MSN, AGNP-C, FCCP.


  • Boost procedural knowledge and skills during hands-on simulation sessions

    Boost procedural knowledge and skills during hands-on simulation sessions

    Simulation courses during CHEST 2026 will empower clinicians to solve the problems they encounter in day-to-day practice using the latest procedural equipment and techniques.


  • Grow your career and connect to your community at CHEST 2026

    Grow your career and connect to your community at CHEST 2026

    CHEST Networks and Interest Groups will help attendees find their home within a vibrant community, contribute to impactful initiatives, and form bonds that outlast the meeting itself.



  • Airways disease at CHEST 2026: Cutting-edge updates and controversies in COPD, bronchiectasis, asthma, and more

    Airways disease at CHEST 2026: Cutting-edge updates and controversies in COPD, bronchiectasis, asthma, and more

    For clinicians who treat airways disease, CHEST 2026 will offer a guideline-driven curriculum built around what’s new, immediately applicable, and possibly even controversial, said Dharani K. Narendra, MD, FCCP.


  • Pulmonary vascular disease and cardiovascular medicine at CHEST 2026: PH, PE, CTEPH, HFpEF, and more

    Pulmonary vascular disease and cardiovascular medicine at CHEST 2026: PH, PE, CTEPH, HFpEF, and more

    Sessions at CHEST 2026 will include talks on pulmonary hypertension (PH), pulmonary embolism (PE), chronic thromboembolic pulmonary hypertension (CTEPH), heart failure with preserved ejection fraction (HFpEF), and more, said Oksana Shlobin, MD, FCCP.